Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GROC Regimen for Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma
NCT01538641Phase 2Completed
- Sponsor
- Auxilio Mutuo Cancer Center
- Start
- Oct 2003
- Primary completion
- Aug 2007
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of gemcitabine, oxaliplatin, rituximab in non-Hodgkin lymphoma (NHL), sponsored by Auxilio Mutuo Cancer Center. Started Oct 2003; status: completed.
02
Drugs
gemcitabineoxaliplatinrituximab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01538641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01538641.